Author Correction: Sema3C signaling is an alternative activator of the canonical WNT pathway in glioblastoma

Nat Commun. 2023 Sep 27;14(1):6018. doi: 10.1038/s41467-023-41842-1.

Jing Hao¹, Xiangzi Han¹, Haidong Huang¹, Xingjiang Yu¹, Jiankang Fang¹, Jianjun Zhao¹, Richard A Prayson^{2

3}, Shideng Bao¹, Jennifer S Yu^{4

5

6}

¹ Center for Cancer Stem Cell Biology, Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH, 44195, USA.
² Department of Anatomic Pathology, Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH, 44195, USA.
³ Burkhardt Brain Tumor and Neuro-Oncology Center, Neurological Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH, 44195, USA.
⁴ Center for Cancer Stem Cell Biology, Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH, 44195, USA. yuj2@ccf.org.
⁵ Burkhardt Brain Tumor and Neuro-Oncology Center, Neurological Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH, 44195, USA. yuj2@ccf.org.
⁶ Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH, 44195, USA. yuj2@ccf.org.

No abstract available

Publication types